Molecular Partners Ag (MOLN) Non-Current Deffered Revenue (2020 - 2023)

Molecular Partners Ag (MOLN) has reported Non-Current Deffered Revenue for 4 consecutive years, with $1.6 million the latest figure, recorded in Q2 2023.

• Quarterly Non-Current Deffered Revenue fell 71.81% year-over-year to $1.6 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.6 million (down 71.81% YoY) and the FY2022 annual result came in at $3.8 million, down 49.73% from the prior year.
• Non-Current Deffered Revenue fell to $1.6 million in Q2 2023 per MOLN's latest filing, from $3.8 million in the prior quarter.
• Over the last five years, Non-Current Deffered Revenue for MOLN reached as high as $7.5 million in Q4 2021 and fell as low as $1.6 million in Q2 2023.
• A 4-year average of $4.3 million and a median of $3.8 million in 2022 frame the typical range for Non-Current Deffered Revenue.
• Annual changes were most pronounced in 2021 — Non-Current Deffered Revenue jumped 131.01% — and 2023, when it slumped 71.81%.
• Year by year, Non-Current Deffered Revenue stood at $3.3 million in 2020, then soared by 131.01% to $7.5 million in 2021, then tumbled by 49.73% to $3.8 million in 2022, then sank by 58.14% to $1.6 million in 2023.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $1.6 million, $3.8 million, and $5.6 million for Q2 2023, Q4 2022, and Q2 2022 respectively.